You are here : Version Anglaise > News & About > Co-accredited Master's programs
-
Partager cette page
Master's in Cancer
© Eric Le Roux, Université Claude Bernard Lyon 1
This Master's degree aims to train future professionals in cancer research and engineering. The Biology of Cancer (BC) track enables students to develop skills in the biological mechanisms of cancer. The IT track enables students to develop skills in clinical research and animal oncology. And finally, the 3.0 track enables students to develop skills in the ethical analysis and management of digital patient data.
CURRICULUM
The Master’s program offers three different tracks:• Biology of cancer (BC);
• Therapeutic innovations in oncology (IT);
• Oncology 3.0: -omics approaches to individualized medicine (3.0).
First year Master’s
The first semester includes course units covering the biological mechanisms of cancer, immunology, biostatistics/bioinformatics, epidemiology, cancer models, clinical research. In the second semester, a flexible internship that enables students to go abroad for 6 months.
Second year BC Master’s
The third semester includes an internship worth 21 ECTS and a course unit covering scientific news. During the fourth semester, an internship worth 24 ECTS.
Second year IT Master’s
Second year 3.0 Master’s
PREREQUISITES FOR ADMISSION
LIST OF TEACHING UNITS
- Environmental factors and carcinogenesis
- Europe EU
- Patient-oriented cancer studies
- Metastases, migration and EMT
- Economics of health and cancer
- Targeted cancer destruction
- Innovation and industrial property
- Pharmaceutical company strategy & MED technologies
- Drug Delivery System
- Targeted therapy, cancer and small molecules
- Biostatistics/Bioinformatics
- Tissue & Cell Engineering
COST OF THE TRAINING PROGRAM
University registration fee
APPLICATION
See website
NUMBER OF GRADUATES
About 80 per year
TEACHING LANGUAGE
Classes are given in English and in French
COORDINATORS
Prof. Caroline Moyret-Lalle: Program director for the course and program director for the first year of the Master’s programProf. Agnès Bernet: Program director for the Biology of Cancer trackProf. Charles Dumontet et Dr Hichem Mertani: Program directors for the Therapeutic Innovations in Oncology trackDr Claire Bardel et Dr Nora Moumjid: Program directors for the Oncology 3.0 track: -omics approaches to individualized medicine
UNIVERSITIES / INSTITUTIONS CO-CERTIFYING THE PROGRAM
Université Claude Bernard Lyon 1 and VetAgro Sup
CONTACT INFORMATION
Phone number: +33 (0) 4 78 77 71 98
caroline.moyret-lalle@univ-lyon1.fr
carole.vernay@univ-lyon1.fr